These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32738856)

  • 1. Future directions in cardiovascular disease risk prediction.
    Doust JA; Bonner C; Bell KJL
    Aust J Gen Pract; 2020 Aug; 49(8):488-494. PubMed ID: 32738856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2023 Australian guideline for assessing and managing cardiovascular disease risk.
    Nelson MR; Banks E; Brown A; Chow CK; Peiris DP; Stocks NP; Davies Ao R; Raffoul N; Kalman L; Bradburn E; Jennings G
    Med J Aust; 2024 May; 220(9):482-490. PubMed ID: 38623719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting the choice of a new cardiovascular risk equation for Australia.
    Brown S; Banks E; Woodward M; Raffoul N; Jennings G; Paige E
    Med J Aust; 2023 Aug; 219(4):173-186. PubMed ID: 37496296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
    Robinson T; Jackson R; Wells S; Kerr A; Marshall R
    N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new selection method to increase the health benefits of CVD prevention strategies.
    Lagerweij GR; de Wit GA; Moons KG; van der Schouw YT; Verschuren WM; Dorresteijn JA; Koffijberg H;
    Eur J Prev Cardiol; 2018 Apr; 25(6):642-650. PubMed ID: 29411690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
    N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators.
    Wilson N; Selak V; Blakely T; Leung W; Clarke P; Jackson R; Knight J; Nghiem N
    N Z Med J; 2016 Mar; 129(1431):85-92. PubMed ID: 27005878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New Zealand.
    Kerr A; Wells S; Moffitt A; Lund M; Kreichbaum J; Harwood M; Jackson R
    N Z Med J; 2019 Aug; 132(1500):89-94. PubMed ID: 31415503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?
    Bonner C; Bell K; Jansen J; Glasziou P; Irwig L; Doust J; McCaffery K
    BMC Cardiovasc Disord; 2018 Feb; 18(1):19. PubMed ID: 29409444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
    Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
    Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
    Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
    J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort.
    Robinson T; Elley CR; Wells S; Robinson E; Kenealy T; Pylypchuk R; Bramley D; Arroll B; Crengle S; Riddell T; Ameratunga S; Metcalf P; Drury PL
    J Prim Health Care; 2012 Sep; 4(3):181-8. PubMed ID: 22946065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?
    Kerr AJ; Broad J; Wells S; Riddell T; Jackson R
    Heart; 2009 Feb; 95(2):125-9. PubMed ID: 18381374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.